Repetitive Transcranial Magnetic Stimulation (rTMS) Compared or Associated With Venlafaxine for Depressive Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 13 Feb 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 12 Jul 2011 Actual initiation date (Jun 2011) added as reported by ClinicalTrials.gov.
- 12 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.